EP 3968949 A1 20220323 - TRIAMCINOLONE ACETONIDE-LOADED LIPOSOMES TOPICAL OPHTHALMIC FORMULATIONS FOR PREVENTION OF MACULAR THICKENING AND ITS ASSOCIATED VISUAL OUTCOMES AFTER LENS SURGERY
Title (en)
TRIAMCINOLONE ACETONIDE-LOADED LIPOSOMES TOPICAL OPHTHALMIC FORMULATIONS FOR PREVENTION OF MACULAR THICKENING AND ITS ASSOCIATED VISUAL OUTCOMES AFTER LENS SURGERY
Title (de)
TOPISCHE OPHTHALMOLOGISCHE FORMULIERUNGEN VON TRIAMCINOLON-ACETONID-GELADENEN LIPOSOMEN ZUR VERHINDERUNG VON MAKULADEVERDICKUNG UND DAMIT ASSOZIIERTE VISUELLE ERGEBNISSE NACH EINEM LINSENCHIRURGISCHEN EINGRIFF
Title (fr)
FORMULATIONS OPHTALMIQUES TOPIQUES CONTENANT DES LIPOSOMES CHARGÉS D'ACÉTONIDE DE TRIAMCINOLONE POUR LA PRÉVENTION DE L'ÉPAISSISSEMENT MACULAIRE ET DE SES RÉSULTATS VISUELS ASSOCIÉS APRÈS UNE CHIRURGIE DU CRISTALLIN
Publication
Application
Priority
- US 201962848907 P 20190516
- US 201916426712 A 20190530
- US 2020031417 W 20200505
Abstract (en)
[origin: WO2020231670A1] The invention relates to triamcinolone acetonide-loaded liposomes topical ophthalmic formulations for prevention of macular thickening and its associated visual outcomes after lens surgery. The liposomal formulation comprises thermodynamically self-forming liposomes which are useful in topical form to treat posterior segment diseases of the eye.
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 31/58 (2006.01); A61P 27/02 (2006.01)
CPC (source: EP)
A61K 9/0048 (2013.01); A61K 9/1271 (2013.01); A61K 31/58 (2013.01); A61P 27/02 (2017.12)
Citation (search report)
See references of WO 2020231670A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020231670 A1 20201119; WO 2020231670 A9 20210107; EP 3968949 A1 20220323; MX 2021014000 A 20211210
DOCDB simple family (application)
US 2020031417 W 20200505; EP 20727542 A 20200505; MX 2021014000 A 20200505